Save Share Apply
Synklino
Copenhagen
Share Save

Student assistant for ambitious biotech company

SYNKLINO is developing the first drug candidate, SYN002, for treatment of CMV infection in transplant recipients. To help us in our endeavors to improve lives of transplant patients through science, we are now looking for an experienced and motivated candidate to the following position:

STUDENT ASSISTANT FOR AMBITIOUS BIOTECH COMPANY

We are seeking a highly motivated student assistant to work on average 8 hours per week with office and administrative tasks. You will report to the Executive Assistant but will collaborate with the whole Synklino team including senior management.

We are looking for a motivated and proactive team player who is very service-minded, dependable, and enjoys a fast-paced environment. Furthermore, the ideal candidate will have outstanding communication and interpersonal skills.

Key Responsibilities:

Office Management

  • Weekly grocery shopping at nemlig.com
  • Buying office supplies
  • Cleaning kitchen and coffee machine
  • Practical assistance during meetings

Administrative tasks

  • Follow-up and archiving of Quality training documents
  • Updating templates

Approx. 70 % of your tasks will be ad hoc support to the Executive Assistant and Finance Manager.

Qualifications and Experience

  • Proficiency in Microsoft Office Suite (Microsoft Outlook, Word, Excel and PowerPoint)
  • High level of proficiency in written and spoken English and Danish

Applying for the job:

Please contact Mette Bøgh Winckler, Executive Assistant, phone: +45 26 25 11 71 if you have questions. To apply for the position please email cover letter and CV to: job@synklino.com, and write “Student Assistant” in the subject. Applications will be evaluated as they are received, and candidates invited for interview on a rolling basis.

The Company:

Synklino is an ambitious privately held biotech company located in Copenhagen. Synklino was founded in 2017, and has a drug candidate; SYN002, for treatment of CMV in transplant patients, which is in development, as well as a technology platform for targeting chronic virus infections.

Apply